IL98075A0 - Azabenzimidazoles in the treatment of asthma,arthritis and related diseases - Google Patents

Azabenzimidazoles in the treatment of asthma,arthritis and related diseases

Info

Publication number
IL98075A0
IL98075A0 IL98075A IL9807591A IL98075A0 IL 98075 A0 IL98075 A0 IL 98075A0 IL 98075 A IL98075 A IL 98075A IL 9807591 A IL9807591 A IL 9807591A IL 98075 A0 IL98075 A0 IL 98075A0
Authority
IL
Israel
Prior art keywords
azabenzimidazoles
asthma
arthritis
treatment
related diseases
Prior art date
Application number
IL98075A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL98075A0 publication Critical patent/IL98075A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL98075A 1990-05-09 1991-05-07 Azabenzimidazoles in the treatment of asthma,arthritis and related diseases IL98075A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52119990A 1990-05-09 1990-05-09

Publications (1)

Publication Number Publication Date
IL98075A0 true IL98075A0 (en) 1992-06-21

Family

ID=24075786

Family Applications (1)

Application Number Title Priority Date Filing Date
IL98075A IL98075A0 (en) 1990-05-09 1991-05-07 Azabenzimidazoles in the treatment of asthma,arthritis and related diseases

Country Status (28)

Country Link
EP (1) EP0533695B1 (en, 2012)
JP (1) JPH0678340B2 (en, 2012)
CN (1) CN1057839A (en, 2012)
AP (1) AP224A (en, 2012)
AT (1) ATE112567T1 (en, 2012)
AU (1) AU642265B2 (en, 2012)
BG (1) BG97059A (en, 2012)
BR (1) BR9106433A (en, 2012)
CA (1) CA2080476A1 (en, 2012)
DE (1) DE69104481T2 (en, 2012)
DK (1) DK0533695T3 (en, 2012)
ES (1) ES2061247T3 (en, 2012)
FI (1) FI925053A0 (en, 2012)
GT (1) GT199100031A (en, 2012)
HU (1) HUT62894A (en, 2012)
IE (1) IE911553A1 (en, 2012)
IL (1) IL98075A0 (en, 2012)
MA (1) MA22151A1 (en, 2012)
MY (1) MY105512A (en, 2012)
NO (1) NO924290D0 (en, 2012)
NZ (1) NZ238089A (en, 2012)
PE (1) PE26691A1 (en, 2012)
PT (1) PT97616A (en, 2012)
RO (1) RO109450B1 (en, 2012)
TW (1) TW205549B (en, 2012)
WO (1) WO1991017163A1 (en, 2012)
YU (1) YU81191A (en, 2012)
ZA (1) ZA913497B (en, 2012)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
AU5016793A (en) * 1992-08-20 1994-03-15 Cytomed, Inc Dual functional anti-inflammatory and immunosuppressive agents
US6372770B1 (en) 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
CN1308622A (zh) * 1998-05-12 2001-08-15 美国家用产品公司 用于治疗胰岛素抗性和高血糖的联苯基氧代－乙酸
US6232322B1 (en) 1998-05-12 2001-05-15 American Home Products Corporation Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6310081B1 (en) 1999-05-10 2001-10-30 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
JP2016537398A (ja) * 2013-09-13 2016-12-01 コーテンドー エービー（ピーユービーエル）Ｃｏｒｔｅｎｄｏ Ａｂ（Ｐｕｂｌ） 新規なチトクロムｐ４５０阻害剤及びこれらの使用方法
CN105348182B (zh) * 2014-08-24 2018-04-13 复旦大学 2‑烷氧基苯甲酰芳胺类化合物及其药物用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8401486A1 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
GB8804439D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Dihydropyridines
GB8822170D0 (en) * 1988-09-21 1988-10-26 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
FI925053L (fi) 1992-11-06
RO109450B1 (ro) 1995-02-28
HUT62894A (en) 1993-06-28
MA22151A1 (fr) 1991-12-31
EP0533695B1 (en) 1994-10-05
WO1991017163A1 (en) 1991-11-14
GT199100031A (es) 1992-10-30
IE911553A1 (en) 1991-11-20
HU9203496D0 (en) 1993-01-28
ZA913497B (en) 1992-12-30
JPH05505619A (ja) 1993-08-19
MY105512A (en) 1994-10-31
DK0533695T3 (da) 1995-01-09
AP224A (en) 1992-10-27
AU7867191A (en) 1991-11-27
PE26691A1 (es) 1991-10-21
AP9100259A0 (en) 1991-07-31
EP0533695A1 (en) 1993-03-31
CA2080476A1 (en) 1991-11-10
CN1057839A (zh) 1992-01-15
BR9106433A (pt) 1993-05-04
DE69104481T2 (de) 1995-02-09
FI925053A7 (fi) 1992-11-06
ATE112567T1 (de) 1994-10-15
YU81191A (sh) 1994-06-10
TW205549B (en, 2012) 1993-05-11
NO924290L (no) 1992-11-06
NO924290D0 (no) 1992-11-06
NZ238089A (en) 1992-10-28
JPH0678340B2 (ja) 1994-10-05
PT97616A (pt) 1992-03-31
BG97059A (bg) 1993-12-24
DE69104481D1 (de) 1994-11-10
AU642265B2 (en) 1993-10-14
ES2061247T3 (es) 1994-12-01
FI925053A0 (fi) 1992-11-06

Similar Documents

Publication Publication Date Title
DE3565699D1 (en) Fibrous absorption body for use in disposable articles and method for the production thereof
GB2265297B (en) Sterilisation process in the manufacture of snuff
DE69117656D1 (de) Therapiehandschuh und Herstellungsverfahren
EG18730A (en) Substituted tetralin, chromans and related compounds in the treatment of asthma, arthritis and related diseases
EP0458333A3 (en) Polyisocyanato-isocyanurate, and preparation process and use of the same
ZA924221B (en) Arylethers,their manufacture and methods of treatment
EP0243968A3 (en) Diacetylrhein salts and their therapeutical use in the treatment of arthritis
EP0499467A3 (en) Use of quinones in the treatment of cancer or aids
AP9100259A0 (en) Azabenzimidazoles in the treatment of asthma,arthritis and related diseases
EP0437026A3 (en) Use of tandospirone in the treatment of depression
ZA924127B (en) New hetaryloxy-beta-carbolines,their production and use in pharmaceutical agents
EP0496148A3 (en) Improvements in the treatment of ashes
EP0410554A3 (en) 14,17-alpha-ethano- and ethano-estratrienes, process for their production and their use in the production of pharmaceuticals
EP0427427A3 (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
ZA918175B (en) Columnar body and process for the production thereof
FI923546A7 (fi) Tetraliini- ja kromaanijohdannaisia, jotka ovat käyttökelpoisia astman ,niveltulehduksen ja vastaavien sairauksien hoidossa
SG47098A1 (en) Diamines in the treatment of arrhythmia
AU641157B2 (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma
HU911086D0 (en) Process for the production and use of 2-dezoxy-d-treo-pentofluoranozides and intermediers thereof
AU2153092A (en) Spirofurane derivatives and their use in the treatment of neurological disorders
EP0407016A3 (en) Use of benzodioxinopyrrole derivatives in the treatment of anxiety
IL109356A0 (en) N-substituted-2-azetidinones and their use in the preparation of n-unsubstituted-2-azetidinones
IL127040A0 (en) Use of substituted azaspirane in the treatment of asthma
ZA879420B (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders
GB9319940D0 (en) Variable impedance in the treatment of sleep apnea